Keywords
Blood Transfusion
Anemia
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Analyze blood component requests in 2022 at a hospital in Belém, Pará, considering epidemiological, clinical, and laboratory findings related to the indication of these blood components. Methods: This is an observational, descriptive, and retrospective study, with data collection done through the institution's database system, from January to December 2022, with subsequent statistical analysis of the findings and tabulation of the results found. Results: A total of 879 transfusions were identified in the period, with a predominance of females (71.7%) with a mean age of 44 years. Most transfusions occurred in the intensive care unit (49.1%), with a predominance of hematological diseases (29.7%) and infectious diseases (16%). The analysis also revealed that 96.9% of requests were in compliance with established protocols. These findings indicate that blood components are used appropriately in most situations, although they highlight the need for ongoing monitoring and education on transfusions to reduce risks. Conclusion: The transfusion profile in the hospital analyzed is in line with current guidelines, reflecting responsible practice in the use of blood components. The importance of continued collection and analysis of transfusion data is highlighted to improve management policies and ensure patient safety.
References
BOLCATO M, et al. Patient blood management: The best approach to transfusion medicine risk management. TransfusionandApheresis Science, 2020; 59(4):102779.
BORCHARDT AC, et al. Blood components requests at an orthopedic hospital: a critical survey. Hematology, TransfusionandCellTherapy. 2020; 42(1): 25–32.
BRASIL. Ministério da Saúde. ANVISA. RDC nº 153 de 14 de junho de 2004. Regulamento técnico para procedimentos hemoterápicos. Diário official da união: Brasília, 2013. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2004/rdc0153_14_06_2004.html. Acesso em: 08/12/2024.
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada e Temática. Guia para uso de hemocomponentes. 2. ed., 1. reimpr. Brasília: Ministério da Saúde, 2015; 136p.
CÉSPEDES IC, et al. Patient Blood Management Program Implementation: Comprehensive Recommendations and Practical Strategies. BrazilianJournalof Cardiovascular Surgery, 2024; 39(5): e20240205.
DALVA CASA, et al. Perfil das transfusões realizadas nas unidades de clínica médica e terapia intensiva de um hospital do sertão central do Ceará.HematologyTransfusionAndCellTherapy, 2024; 46(S4): S1−S1267
DUARTE GC, et al. Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system. Hematology, TransfusionandCellTherapy. 2022; 44(3): 374–8.
GAMMON RR, et al. Patient Blood Management and Its Role in Supporting Blood Supply. JournalofBlood Medicine, 2023; 14: 595-611.
GONCALEZ TT, et al. NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Blood transfusion utilization and recipient survival at Hospital das Clinicas in Sao Paulo, Brazil. Transfusion, 2012; 52: 729-38.
MONTANO-PEDROSO JC, et al. Consenso da associação brasileira de hematologia, hemoterapia e terapia celular sobre o manejo do sangue do paciente: Histórico e cenário do manejo do sangue do paciente no mundo e no Brasil. Hematology, TransfusionandCellTherapy, 2024; 46: 1–4.
NAUFEL JUNIOR CR, et al. Estudo do perfil de solicitações para transfusão de hemocomponentes em hospital universitário. Revista Médica do Paraná, 2016; 74(1): 44-50.
OKOROIWU HU, OKAFOR IM. Demographic characteristics of blood and blood components transfusion recipients and pattern of blood utilization in a tertiary health institution in southern Nigeria. BMC Hematol, 2018; 31;18(1).
RAVAL JS, et al. Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications. American Family Physician, 2020; 102(1): 30–8.
SANTIS GCD, et al. Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance. Hematology, TransfusionandCellTherapy, 2024;46:67–71.
SEKINE L, et al. Análise do perfil de solicitações para transfusão de hemocomponentes no Hospital de Clínicas de Porto Alegre no ano de 2005. Revista Brasileira de Hematologia e Hemoterapia, 2008; 30(3): 208-212.
SILVA ALO. Avaliação do impacto da transfusão emergencial de hemocomponentes ABO não idênticos na sobrevida e gravidade dos pacientes vítimas de trauma. Dissertação (Mestre em Ciência) – Instituto de Medicina Tropical. Universidade de São Paulo, São Paulo, 2019; 55p.
STORCH EK, et al. Review of current transfusion therapy and blood banking practices. Blood Reviews, 2019; 38: 100593.
TAGLIARI AP, et al. Eventos adversos e fatores de risco da transfusão sanguínea em cirurgia cardiovascular: um estudo de coorte prospectivo. InternationalJournalof Cardiovascular Sciences, 2019; 32(6): 565-572.
TANHEHCO YC. Red Blood Cell Transfusion. Clinics in Laboratory Medicine, 2021; 41(4):611–9.
TODESCHINI K, et al. Perfil epidemiológico de pacientes transfundidos em hospital particular de grande porte na Zona Oeste do RJ. Hematology, TransfusionAndCellTherapy, 2023; 45: S758–9.